CTABF (Canntab Therapeutics) Current Deferred Revenue : $0.00 Mil (As of Feb. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Canntab Therapeutics Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Canntab Therapeutics's current deferred revenue for the quarter that ended in Feb. 2023 was $0.00 Mil.

Canntab Therapeutics Current Deferred Revenue Historical Data

The historical data trend for Canntab Therapeutics's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canntab Therapeutics Current Deferred Revenue Chart

Canntab Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

May17

May18

May19

May20

May21

May22

Current Deferred Revenue

Get a 7-Day Free Trial

0.03

Canntab Therapeutics Quarterly Data
	Mar18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Canntab Therapeutics Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Canntab Therapeutics's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Canntab Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canntab Therapeutics Ltd (OTCPK:CTABF) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9

Website

https://www.canntab.ca

Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.